Conditionally essential nutrients: Choline, inositol, taurine, arginine, glutamine, and nucleotides

Neonatal Nutrition and Metabolism, Second Edition

Volumn 9780521824552, Issue , 2006, Pages 299-311

  Carver, Jane ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856887785     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511544712.020     Document Type: Chapter

References (147)

1. Uauy, R., Greene, H., Heird, W. Conditionally essential nutrients: cysteine, taurine, tyrosine, arginine, glutamine, choline, inositol, and nucleotides. In Tsang, R., Lucas, A., Uauy, R., Zlotkin, S., eds. Nutritional Needs of the Preterm Infant. Pawling, NY: CaduceusMedical Publishers; 1993:267-80.
2. Blusztajn, J. K. Choline, a vital amine. Science1998;281:794-5.
3. Zeisel, S. H. Choline: an essential nutrient for humans. Nutrition2000;16:669-71.
4. Zeisel, S. H. Choline: essential for brain development and function. InBarness, L. A., ed. Advances in Pediatrics. Chicago, IL:Mosby-Year Book; 1997:263-95.
5. Zeisel, S.H. Choline:neededfornormaldevelopmentofmemory. J. Am. Coll. Nutr. 2000;19:528S-31S.
6. Buchman, A. L., Ament, M. E., Sohel, M. et al. Choline deficiency causes reversible hepatic abnormalities in patients receiving parenteral nutrition: proof of a human choline requirement: a placebo-controlled trial. J. Parenter. Enteral Nutr. 2001;25:260-8.
7. Chawla, R. K., Wolf, D. C., Kutner, M. H., Bonkovsky, H. L. Cholinemaybeanessentialnutrient inmalnourishedpatients with cirrhosis. Gastroenterology1989;97:1514-20.
8. Sheard, N., Tayek, J., Bistrian, B., Blackburn, G., Zeisel, S. H. Plasma choline concentrations in humans fed parenterally. Am. J. Clin. Nutr. 1986;43:219-24.
9. Kaminski, D. L., Adams, A., Jellinek, M. The effect of hyperalimentation on hepatic lipid content and lipogenic enzyme activity in rats and man. Surgery1980;88:93-100.
10. Chandar, N., Lombardi, B. Liver cell proliferation and incidence of hepatocellular carcinomas in rats fed consecutively a choline-devoid and a choline-supplemented diet. Carcinogenesis1988;9:259-63.
11. Buchman, A. Relation between choline and carnitine homeostasis. Am. J. Clin. Nutr. 1997;65:574-5.
12. Dodson, W., Sachan, D. Choline supplementation reduces urinary carnitine excretion in humans. Am. J. Clin. Nutr. 1996;63:904-10.
13. Meck, W. H., Williams, C. L. Perinatal choline supplementation increases the threshold for chunking in spatial memory. Neuroreport1997;8:3053-9.
14. Meck, W. H., Williams, C. L. Characterization of the facilitative effects of perinatal choline supplementation on timing and temporal memory. Neuroreport1997;8:2831-5.
15. Meck, W. H., Williams, C. L. Choline supplementation during prenatal development reduces proactive interference in spatial memory. Brain Res. Dev. Brain Res. 1999;118:51-9.
16. Albright, C.D., Friedrich, C.B., Brown, E. C., Mar, M. H., Zeisel, S. H. Maternal dietary choline availability alters mitosis, apoptosis and the localization of TOAD-64 protein in the developing fetal rat septum. Brain Res. Dev. Brain Res. 1999;115: 123-9.
17. Albright, C. D., Mar, M. H., Friedrich, C. B. et al. Maternal choline availability alters the localization of p15Ink4B and p27Kip1 cyclin-dependent kinase inhibitors in the developing fetal rat brain hippocampus. Dev. Neurosci. 2001;23: 100-6.
18. Cohen, E., Wurthman, R. Brain acetylcholine: control by dietary choline. Science1976;191:561-2.
19. Fernstrom, J. D. Can nutrient supplements modify brain function? Am. J. Clin. Nutr. 2000;71:1669S-75S.
20. Klein, J., Koppen, A., Loffelholz, K.Regulation of free choline in rat brain: dietary and pharmacological manipulations. Neurochem. Intl. 1998;32:479-85.
21. Klein, C. J., ed. Nutrient requirements for preterm infant formulas. A report fromthe American Society forNutritional Sciences, Life Sciences Research Office. J. Nutr. 2002;132:1431S-49S.
22. Raiten, D., Talbot, J., Waters, J. eds. Assessment of nutrient requirements for infant formulas. A report fromthe American Society forNutritional Sciences, Life SciencesResearch Office. J. Nutr. 1998;128:2059S-293S.
23. Holub, B. J. The nutritional importance of inositol and the phosphoinositides. N. Engl. J.Med. 1992;326:1285-7.
24. Holub, B. J. The cellular forms and functions of the inositol phospholipids and their metabolic derivatives. Nutr. Rev. 1987;45:65-71.
25. Kirk, C. J., Maccallum, S. H., Michell, R. H., Barker, C. J. Inositol phosphates in receptor-mediated cell signaling: metabolic origins and interrelationships. Biotechnol. Appl. Biochem. 1990;12:489-95.
26. Holub, B. J. Metabolism and function of myo-inositol and inositol phospholipids. Ann. Rev. Nutr. 1986;6:563-97.
27. Lewin, L. M., Melmed, S., Passwell, J. H. et al. Myoinositol in human neonates: serum concentrations and renal handling. Pediatr. Res. 1978;12:3-6.
28. Bromberger, P., Hallman, M. Myoinositol in small preterm infants: relationship between intake and serum concentration. J. Pediatr. Gastroenterol. Nutr. 1986;5:455-8.
29. Burton, L. E., Ray, R. E., Bradford, J. R. et al.Myo-inositol metabolism in the neonatal and developing rat fed a myoinositol-free diet. J. Nutr. 1976;106:1610-16.
30. Beach, D. C., Flick, P. K. Early effect of myo-inositol deficiency on fatty acid synthetic enzymes of rat liver. Biochim. Biophys. Acta. 1982;711:452-9.
31. Clements, R. S., Jr., Vourganti, B., Kuba, T., Oh, S. J., Darnell, B. Dietary myo-inositol intake and peripheral nerve function in diabetic neuropathy.Metabolism 1979;28:477-83.
32. Haneda, M., Kikkawa, R., Arimura, T. et al. Glucose inhibits myo-inositol uptake and reducesmyo-inositol content in cultured rat glomerular mesangial cells.Metabolism 1990;39:40-5.
33. Pugliese, G., Tilton, R. G., Speedy, A. et al.Modulation ofhemodynamic and vascular filtration changes in diabetic rats by dietary myo-inositol. Diabetes 1990;39:312-22.
34. Kim, J., Kyriazi, H., Greene, D. A. Normalization of Na(+)−K(+)−ATPase activity in isolated membrane fraction from sciatic nerves of streptozocin-induced diabetic rats by dietary myo-inositol supplementation in vivo or protein kinase C agonists in vitro. Diabetes1991;40:558-67.
35. Van Straaten, H. W., Copp, A. J. Curly tail: a 50-year history of the mouse spina bifida model. Anat. Embryol. (Berl). 2001;203:225-37.
36. Pereira, G. R., Baker, L., Egler, J., Corcoran, L., Chiavacci, R. Serum myoinositol concentrations in premature infants fed human milk, formula for infants, and parenteral nutrition. Am. J. Clin. Nutr. 1990;51:589-93.
37. Friedman, C. A., McVey, J., Borne, M. J. et al. Relationship between serum inositol concentration and development of retinopathy of prematurity: a prospective study. J. Pediatr. Ophthalmol. Strabismus2000;37:79-86.
38. Hallman, M., Arjomaa, P., Hoppu, K. Inositol supplementation in respiratory distress syndrome: relationship between serum concentration, renal excretion, and lung effluent phospholipids. J. Pediatr. 1987;110:604-10.
39. Hallman, M., Bry, K., Hoppu, K., Lappi, M., Pohjavuori, M. Inositol supplementation in premature infants with respiratory distress syndrome. N. Engl. J. Med. 1992;326: 1233-9.
40. Carver, J. D., Stromquist, C. I., Benford, V. J. et al. Postnatal inositol levels in preterm infants. J. Perinatol. 1997;17: 389-92.
41. Hallman, M., Saugstad, O. D., Porreco, R. P., Epstein, B. L., Gluck, L. Role of myoinositol in regulation of surfactant phospholipids in the newborn. Early Hum. Dev. 1985;10:245-54.
42. Howlett, A., Ohlsson, A. Inositol for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev. 2000:CD000366.
43. Hallman, M., Slivka, S., Wozniak, P., Sills, J. Perinatal development of myoinositol uptake into lung cells: surfactant phosphatidylglycerol and phosphatidylinositol synthesis in the rabbit. Pediatr. Res. 1986;20:179-85.
44. Hallman, M., Jarvenpaa, A. L., Pohjavuori, M. Respiratory distress syndrome and inositol supplementation in preterm infants. Arch. Dis. Child. 1986;61:1076-83.
45. Chesney, R.W., Helms, R. A., Christensen, M. et al. Anupdated view of the value of taurine in infant nutrition. Adv. Pediatr. 1998;45:179-200.
46. Boehm, G., Braun, W., Moro, G., Minoli, I. Bile acid concentrations in serum and duodenal aspirates of healthy preterm infants: effects of gestational and postnatal age. Biol.Neonate. 1997;71:207-14.
47. Strandvik, B., Wahlen, E., Wikstrom, S. A. The urinary bile acid excretion in healthy premature and full-terminfants during the neonatal period. Scand. J. Clin. Lab. Invest. 1994;54: 1-10.
48. Gaull, G. E., Rassin, D. K., Raiha, N. C., Heinonen, K. Milk protein quantity and quality in low-birth-weight infants. III. Effects on sulfur amino acids in plasma and urine. J. Pediatr. 1977;90:348-55.
49. Rassin, D. K., Gaull, G. E., Jarvenpaa, A. L., Raiha, N. C. Feeding the low-birth-weight infant: II. Effects of taurine and cholesterol supplementation on amino acids and cholesterol. Pediatrics. 1983;71:179-86.
50. Sturman, J. A., Gaull, G., Raiha, N. C. Absence of cystathionase inhumanfetal liver: is cysteine essential? Science 1970;169:74-6.
51. Vinton, N. E., Laidlaw, S. A., Ament, M. E., Kopple, J.D.Taurine concentrations in plasma, blood cells, and urine of children undergoing long-termtotal parenteral nutrition. Pediatr. Res. 1987;21:399-403.
52. Neuringer, M., Palackal, T., Sturman, J. A., Imaki, H. Effects of postnatal taurine deprivation on visual cortex development in rhesus monkeys through one year of age. Adv. Exp. Med. Biol. 1994;359:385-92.
53. Neuringer, M., Sturman, J. Visual acuity loss in rhesus monkey infants fed a taurine-free human infant formula. J. Neurosci. Res. 1987;18:597-601.
54. Imaki, H., Jacobson, S. G., Kemp, C. M. et al. Retinal morphology and visual pigment levels in 6-and 12-month-old rhesus monkeys fed a taurine-freehumaninfant formula. J.Neurosci. Res. 1993;36:290-304.
55. Imaki, H., Neuringer, M., Sturman, J. Long-term effects on retina of rhesus monkeys fed taurine-free human infant formula. Adv. Exp.Med. Biol. 1996;403:351-60.
56. Geggel, H. S., Ament, M. E., Heckenlively, J. R., Martin, D. A., Kopple, J. D. Nutritional requirement for taurine in patients receiving long-term parenteral nutrition. N. Engl. J. Med. 1985;312:142-6.
57. Vinton, N. E., Heckenlively, J. R., Laidlaw, S. A. et al. Visual function in patients undergoing long-term total parenteral nutrition. Am. J. Clin. Nutr. 1990;52:895-902.
58. Kopple, J. D., Vinton, N. E., Laidlaw, S. A., Ament, M. E. Effect of intravenous taurine supplementation on plasma, blood cell, and urine taurine concentrations in adults undergoing long-term parenteral nutrition. Am. J. Clin. Nutr. 1990;52: 846-53.
59. Vinton, N. E., Laidlaw, S. A., Ament, M. E., Kopple, J. D. Taurine concentrations in plasma and blood cells of patients undergoing long-termparenteral nutrition. Am. J. Clin. Nutr. 1986;44:398-404.
60. Helms, R. A., Christensen, M. L., Storm, M. C., Chesney, R.W. Adequacy of sulfur amino acid intake in infants receiving parenteral nutrition. J. Nutr. Biochem.1995;6:462-6.
61. Zelikovic, I., Chesney, R. W., Friedman, A. L., Ahlfors, C. E. Taurine depletion in very low birth weight infants receiving prolonged total parenteral nutrition: role of renal immaturity. J. Pediatr. 1990;116:301-6.
62. Han, X., Patters, A. B., Chesney, R. W. Transcriptional repression of taurine transporter gene (TauT) by p53 in renal cells. J. Biol. Chem. 2002;277:39266-73.
63. Sturman, J. A., Messing, J. M., Rossi, S. S., Hofmann, A. F., Neuringer, M. D. Tissue taurine content and conjugated bile acidcompositionof rhesusmonkeyinfantsfedahumaninfant soy-protein formula with or without taurine supplementation for 3 months. Neurochem. Res. 1988;13:311-16.
64. Lima, L., Obregon, F., Cubillos, S., Fazzino, F., Jaimes, I.Taurine as a micronutrient in development and regeneration of the central nervous system. Nutr. Neurosci. 2001;4:439-43.
65. Tyson, J. E., Lasky, R., Flood, D. et al. Randomized trial of taurine supplementation for infants less than or equal to 1, 300-grambirthweight: effect on auditory brainstem-evoked responses. Pediatrics1989;83:406-15.
66. Howard, D., Thompson, D. F. Taurine: an essential amino acid to prevent cholestasis in neonates? Ann. Pharmacother. 1992;26:1390-2.
67. Tazawa, Y., Yamada, M., Nakagawa, M., Konno, Y., Tada, K. Unconjugated, glycine-conjugated, taurine-conjugated bile acid nonsulfates and sulfates in urine of young infants with cholestasis. Acta Paediatr. Scand. 1984;73:392-7.
68. Okamoto, E., Rassin, D. K., Zucker, C. L., Salen, G. S., Heird, W. C. Role of taurine in feeding the low-birth-weight infant. J. Pediatr. 1984;104:936-40.
69. Wasserhess, P., Becker, M., Staab, D. Effect of taurine on synthesis of neutral and acidic sterols and fat absorption in pretermand full-terminfants. Am. J. Clin. Nutr. 1993;58:349-53.
70. Raiha, N. C., Fazzolari-Nesci, A., Boehm, G. Taurine supplementation prevents hyperaminoacidemia in growing term infants fed high-protein cow’s milk formula. Acta Paediatr. 1996;85:1403-7.
71. Zamboni, G., Piemonte, G., Bolner, A. et al. Influenceof dietary taurine on vitamin D absorption. Acta Paediatr. 1993;82:811-15.
72. Redmond, H. P., Stapleton, P. P., Neary, P., Bouchier-Hayes, D. Immunonutrition: the role of taurine. Nutrition1998;14:599-604.
73. Wu, G., Meininger, C., Knabe, D., Baze, F., Rhoads, J. Arginine nutrition indevelopment, healthanddisease.Curr.Opin. Clin. Nutr.Met. Care2000;3:59-66.
74. Heird, W., Nicholson, J., Driscoll, J., Schullinger, J., Winters, R. Hyperammonemia resulting from intravenous alimentation using a mixture of synthetic l-amino acids: a preliminary report. J. Pediatr. 1972;81:162-5.
75. Brunton, J. A., Ball, R. O., Pencharz, P. B. Current total parenteral nutrition solutions for the neonate are inadequate. Curr. Opin. Clin. Nutr.Metab. Care2000;3:299-304.
76. Brooke, O. G., Onubogu, O., Heath, R., Carter, N. D. Human milk and pretermformula compared for effects on growth and metabolism. Arch. Dis. Child. 1987;62:917-23.
77. Tikanoja, T., Simell, O., Viikari, M., Jarvenpaa, A. L. Plasma amino acids in term neonates after a feed of human milk or formula. II. Characteristic changes in individual amino acids. Acta Paediatr. Scand. 1982;71:391-7.
78. Alican, I., Kubes, P. A critical role for nitric oxide in intestinal barrier function and dysfunction. Am. J. Physiol. 1996;270:G225-37.
79. Wu, G. Intestinal mucosal amino acid catabolism. J. Nutr. 1998;128:1249-52.
80. Caplan, M. S., Hedlund, E., Hill, N., MacKendrick, W. The role of endogenous nitric oxide and platelet-activating factor in hypoxia-induced intestinal injury in rats. Gastroenterology1994;106:346-52.
81. Kubes, P. Ischemia-reperfusion in feline small intestine: a role for nitric oxide. Am. J. Physiol. 1993;264:G143-9.
82. MacKendrick, W., Caplan, M., Hsueh, W. Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury in the rat. Pediatr. Res. 1993;34:222-8.
83. Zamora, S. A., Amin, H. J., McMillan, D. D. et al. Plasma Larginine concentrations in premature infants with necrotizing enterocolitis. J. Pediatr. 1997;131:226-32.
84. Becker, R.M., Wu, G., Galanko, J. A. et al.Reducedserumamino acid concentrations in infants with necrotizing enterocolitis. J. Pediatr. 2000;137:785-93.
85. Amin, H., Zamora, S., McMillan, D. et al. Arginine supplementationprevents necrotizing enterocolitis in the premature infant. J. Pediatr. 2002;140:425-31.
86. Neu, J. Arginine supplementation and the prevention of necrotizing enterocolitis in very low birth weight infants. J. Pediatr. 2002;140:389-92.
87. Zamora, S. A., Amin, H. J., McMillan, D. D. et al. Plasma L-arginine concentration, oxygenation index, and systemic blood pressure in premature infants. Crit. Care Med. 1998; 26:1271-6.
88. Castillo, L., DeRojas-Walker, T., Yu, Y.M., et al.Wholebodyarginine metabolism and nitric oxide synthesis in newborns with persistent pulmonary hypertension. Pediatr. Res. 1995;38:17-24.
89. Vosatka, R., Hassoun, P., Harvey-Wilkes, K. Dietary L-arginine prevents fetal growth restriction in rats.Am. J.Obstet.Gynecol. 1998;178:242-6.
90. Helmbrecht, G.D., Farhat, M.Y., Lochbaum, L. et al. L-arginine reverses the adverse pregnancy changes induced by nitric oxide synthase inhibition in the rat. Am. J. Obstet. Gynecol. 1996;175:800-5.
91. Envoy, D., Lieberman, M., Fahey, T., Daly, J. Immunonutrition: the role of arginine. Nutrition1998;14:611-17.
92. Yu, Y.-M., Sheridan, R., Burke, J. et al. Kinetics of plasma arginine and leucine in pediatric burn patients. Am. J. Clin. Nutr. 1996;64:60-6.
93. Cooke, J.P., Tsao, P.Arginine:anewtherapyfor atherosclerosis? Circulation 1997;95:311-12.
94. Wu, G., Meininger, C. J. Arginine nutrition and cardiovascular function. J. Nutr. 2000;130:2626-9.
95. Creager, M. A., Gallagher, S. J., Girerd, X. J. et al. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J. Clin. Invest. 1992;90:1248-53.
96. Drexler, H., Fischell, T. A., Pinto, F. J. et al. Effect of Larginine on coronary endothelial function in cardiac transplant recipients. Relation to vessel wall morphology. Circulation1994;89:1615-23.
97. Peters, H., Border, W. A., Ruckert, M. et al. l-Arginine supplementation accelerates renal fibrosis and shortens life span in experimental lupus nephritis. Kidney Int. 2003;63:1382-92.
98. Andrews, F., Griffiths, R. Glutamine: essential for immune nutrition in the critically ill. Br. J. Nutr. 2002;87:S3-8.
99. Burrin, D. G., Stoll, B. Key nutrients and growth factors for the neonatal gastrointestinal tract. Clin. Perinatol. 2002;29: 65-96.
100. Reeds, P. J., Burrin, D. G. Glutamine and the bowel. J. Nutr. 2001;131:2505S-8S; discussion 2523S-24S.
101. Neu, J., DeMarco, V., Li, N. Glutamine: clinical applications and mechanisms of action. Curr. Opin. Clin. Nutr. Met. Care2002;5:69-75.
102. Karinch, A. M., Pan, M., Lin, C. M., Strange, R., Souba, W. W. Glutamine metabolism in sepsis and infection. J. Nutr. 2001;131:2535S-8S.
103. Andrews, F., Griffiths, R.Glutamine-enhanced nutrition in the critically ill patient. Hosp.Med. 2002;63:144-7.
104. Boelens, P. G., Nijveldt, R. J., Houdijk, A. P., Meijer, S., van Leeuwen, P. A. Glutamine alimentation in catabolic state. J. Nutr. 2001;131:2569S-77S.
105. Houdijk, A. P., Rijnsburger, E. R., Jansen, J. et al. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet1998;352:772-6.
106. Novak, F., Heyland, D. K., Avenell, A., Drover, J. W., Su, X. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit. CareMed. 2002;30:2022-9.
107. Duggan, C., Gannon, J., Walker, W. A. Protective nutrients and functionalfoodsfor the gastrointestinal tract.Am. J. Clin.Nutr. 2002;75:789-808.
108. Kudsk, K. A. Effect of route and type of nutrition on intestinederived inflammatory responses.Am. J. Surg. 2003;185:16-21.
109. Neu, J. Glutamine in the fetus and critically ill low birth weight neonate: metabolism and mechanism of action. J. Nutr. 2001;131:258S-9S.
110. He, Y., Chu, S. H., Walker, W. A. Nucleotide supplements alter proliferation and differentiation of cultured human (Caco-2) and rat (IEC-6) intestinal epithelial cells. J. Nutr. 1993;123:1017-27.
111. Postic, B., Holliday, N., Lewis, P. et al. Glutamine supplementation and deprivation: effect on artificially reared rat small intestinal morphology. Pediatr. Res. 2002;52:430-6.
112. Lacey, J. M., Crouch, J. B., Benfell, K. et al. The effects of glutamine-supplemented parenteral nutrition in premature infants. J. Parenter. Enteral Nutr. 1996;20:74-80.
113. Neu, J., Roig, J., Meetze, W. et al.Enteralglutaminesupplementation for very low birth weight infants decreases morbidity. J. Pediatr. 1997;131:691-9.
114. Dallas, M., Bowling, D., Roig, J., Auestad, N., Neu, J. Enteral glutamine supplementation for very-low-birthweight infants decreases hospital costs. J. Parenter. Enteral Nutr. 1998;22:352-6.
115. des Robert, C., Le Bacquer, O., Piloquet, H., Roze, J. C., Darmaun, D. Acute effects of intravenous glutamine supplementation on protein metabolism in very lowbirthweight infants: a stable isotope study. Pediatr. Res. 2002;51:87-93.
116. Poindexter, B., Ehrenkranz, R. A., Stoll, B. J. et al. Parenteral glutamine supplementation in ELBW infants: a multicenter randomized clinical trial. Pediatr. Res. 2002;51:317A.
117. Vaughn, P., Thomas, P., Clark, R., Neu, J. Enteral glutamine supplementation and morbidity in low-birth-weight infants. Pediatr. Res. 2003;53:437A.
118. Carver, J., Walker, W. The role of nucleotides in human nutrition. J. Nutr. Biochem. 1995;6:58-72.
119. Rudolph, F. B. The biochemistry and physiology of nucleotides. J. Nutr. 1994;124:124S-7S.
120. Janas, L. M., Picciano, M. F. The nucleotide profile of human milk. Pediatr. Res. 1982;16:659-62.
121. Carver, J. D. Dietary nucleotides: effects on the immune and gastrointestinal systems. Acta Paediatrica. 1999;430:83-8.
122. Leach, J. L., Baxter, J. H., Molitor, B. E., Ramstack, M.B., Masor, M. L. Total potential available nucleosides of human milk by stage of lactation. Am. J. Clin. Nutr. 1995;61:1224-30.
123. Thorell, L., Sjöberg, L. B., Hernell, O. Nucleotides in human milk: sources and metabolism by the newborn infant. Pediatr. Res. 1996;40:845-52.
124. Walker, W. A. Exogenous nucleotides and gastrointestinal immunity. Transplant Proc. 1996;28:2438-41.
125. Uauy, R., Stingel, G., Thomas, R., Quan, R. Effect of dietary nucleosides on growth and maturation of the developing gut in the rat. J. Pediatr. Gastroenterol. Nutr. 1990;10: 497-503.
126. López-Navarro, A. T., Ortega, M. A., Peragón, J. et al. Deprivation of dietary nucleotides decreases protein synthesis in the liver and small intestine in rats. Gastroenterology1996;110:1760-9.
127. LeLeiko, N. S., Walsh, M. J., Abraham, S. Gene expression in the intestine: the effect of dietary nucleotides. In Barness, L., DeVivo, D., Kaback, M. et al., eds. Advances in Pediatrics. St. Louis, MO:Mosby-Year Book; 1995:145-69.
128. Sanderson, I. R., He, Y. Nucleotide uptake and metabolism by intestinal epithelial cells. J. Nutr. 1994;124:131S-7S.
129. Tanaka, M., Lee, K., Martinez-Augustin, O. et al. Exogenous nucleotides alter the proliferation, differentiation and apoptosis of human small intestinal epithelium. J. Nutr. 1996;126:424-33.
130. Brunser, O., Espinoza, J., Araya, M., Cruchet, S., Gil, A. Effect of dietary nucleotide supplementation on diarrhoeal disease in infants. Acta Paediatrica1994;83:188-91.
131. Pickering, L. K., Granoff, D. M., Erickson, J. R. et al. Modulation of the immune system by human milk and infant formula containing nucleotides. Pediatrics 1998;101:242-9.
132. Yau, K. T., Huang, C., Chen, W. et al. Effect of nucleotides on diarrhea and immune responses in healthy term infants in Taiwan. J. Pediatr. Gastr. Nutr. 2003;36:37-43.
133. Balmer, S., Hanvey, L., Wharton, B. Diet and faecal flora in the newborn: nucleotides. Arch. Dis. Child. 1994;70: F137-40.
134. Gil, A., Corral, E., Martinez, A., Molina, J. Effects of dietary nucleotides on the microbial pattern of faeces in the at term newborn infants. J. Clin. Nutr. Gastroent. 1986;1:127-32.
135. Carver, J.D., Sosa, R., Zaritt, J., Siktberg, M.R., Meyer, L. Dietary nucleotide effects on superior mesenteric artery blood flowin terminfants. Pediatr. Res. 2000;45:284A.
136. Özkan, H., Ören, H., Erdag, N., Ç evik, N. Breast milk versus infant formulas: effects on intestinal blood flow in neonates. Indian J. Pediatr. 1994;61:703-9.
137. Carver, J. D., Saste, M., Sosa, R. et al. The effects of dietary nucleotides on intestinal blood flow in preterminfants. Pediatr. Res. 2002;52:425-9.
138. Jyonouchi, H., Sun, S., Winship, T., Kuchan, M. J. Dietary ribonucleotides increase antigen-specific type1T-helper cells in the regional draining lymph nodes in young BALB/cJ mice. Nutrition2003;19:41-6.
139. Nagafuchi, S., Hachimura, S., Totsuka, M. et al. Dietary nucleotides can up-regulate antigen-specific Th1 immune responses and suppress antigen-specific IgE responses in mice. Intl. Arch. Aller. Immunol. 2000;122:33-41.
140. Carver, J. D., Pimentel, B., Cox, W. I., Barness, L. A. Dietary nucleotide effects in formula-fed infants. Pediatrics1991;88:359-63.
141. Martinez-Augustin, O., Boza, J. J., Del Pino, J. I. et al.Dietary nucleotides might influence the humoral immune response against cow’s milk proteins in preterm neonates. Biol. Neonate. 1997;7:215-23.
142. Navarro, J., Maldonado, J., Narbona, E. et al. Influence of dietary nucleotides on plasma immunoglobulin levels and lymphocyte subsets of preterminfants. Biofactors 1999;10:67-76.
143. Cosgrove, M., Davies, D. P., Jenkins, H. R. Nucleotide supplementation and growth of term small for gestational age infants. Arch. Dis. Child. 1996;74:F122-5.
144. Pita, M., Fernández, M., De-Lucchi, C. et al. Changes in the fatty acids pattern of red blood cell phospholipids induced by type of milk, dietary nucleotide supplementation, and postnatal age in preterm infants. J. Pediatr. Gastr. Nutr. 1988;7: 740-7.
145. Sánchez-Pozo, A., Ramírez, M., Gil, A. et al. Dietarynucleotides enhance plasma lecithin cholesterol acyl transferase activity and apolipoprotein A-IV concentration in preterm newborn infants. Pediatr. Res. 1995;37:328-33.
146. Henderson, T., Homosh, M., Mehta, N., Angelus, P., Hamosh, P. Red blood cell phospholipid docosahexaenoic acid and archidonic acid concentrations in very low birth weight infants are not affected by nucleotide supplementation of premie formula and are lower than mother’s own milk. Pediatr. Res. 1994;35:313A.
147. Woltil, H. A., van Beusekom, C. M., Siemensma, A. D. et al. Erythrocyte and plasma cholesterol ester long-chain polyunsaturated fatty acids of low-birth-weight babies fed preterm formula with and without ribonucleotides: comparison with human milk. Am. J. Clin. Nutr. 1995;62:943-9.